TRI-CON 2025 Poster Presentations

P01: Migration of Luminex Assays to Deployed Point of Care on Axxin Lateral Flow Array Platform, Presented by Nathan B., Axxin

P02: One-Hour Extraction-Free Loop-Mediated Isothermal Amplification HPV DNA Assay for Point-of-Care Testing in Maputo, Mozambique, Presented by Maria B., Rice University

P03: Unveiling the Power of BioIVT’s Biobank: Generating FFPE Blocks from Laboratory-Replicated FNA of Fresh Frozen Samples, Presented by Cathie M., BioIVT

P04: Thymidine Kinase Activity (TKa) Is a Sensitive Liquid Biomarker for Treatment Dosing Optimization and Monitoring of Drug Efficaciousness in Solid Tumors, Presented by Henrik W., Biovica International AB

P05: ez-CAZy: A Reference Annotation Database Linking Glycoside Hydrolase Sequences to Enzymatic Activity, Presented by Daniel E., California State University, Long Beach

P06: Interpretable Deep Learning Models for Early Detection of Alzheimer’s Disease, Presented by Pooyan K., Case Western Reserve University

P07: Mapping the Tumor Microenvironment at Single-Cell Resolution with Stereo-Seq Spatial Transcriptomics, Presented by Yongfu W., Complete Genomics

P08: Navigating Regulatory Strategy in STI Dx Development: Lessons from a Dx Start-Up, Presented by Patrick V., DCN Dx

P09: Cell-Free DNA and Beyond: A Comprehensive Evaluation of Liquid Biopsy Workflows Across in a Global Clinical Biorepository, Presented by Shawn F., Discovery Life Sciences

P10: Development of IHC-Compatible Monoclonal Antibodies Against Human LRRC15, Presented by Michel F., Ensigna Biosystems, Inc.

P11: Remote Plasma Collection and Testing from Anywhere, Presented by Mahmoud Z., GattaCo, Inc.

P12: BreathBiomics: An Exhaled Breath-Based Noninvasive Diagnostic Device for Respiratory Tract Infections, Presented by Michael M., Johns Hopkins University

P13: Detection of CT/NG through Multi-Specimen Testing: A Comprehensive Analysis of Self-Collected Specimens (2019-2023), Presented by Mariko N., Molecular Testing Labs

P14: Cell-Free DNA for Treatment Monitoring and MRD in BRAF V600E Mutation-Positive Colorectal Cancer, Presented by Takuma I., Nippon Medical School Hospital

P15: Mechanisms of Acquired Resistance to Anti-Angiogenic Agents, Presented by Takeshi Y., Nippon Medical School Hospital

P16: Breaking Barriers in Liquid Biopsy: Scalable Extraction of cfDNA, cfRNA and CTCs from Whole Blood and Plasma, Presented by Nafiseh J., nRichDX

P17: Market-Ready Cell Line-Derived cfDNA Reference Materials for Liquid Biopsy Quality Assurance, Presented by Kirsten S., QD Labs LP

P18: Loop-de-Loop LAMP for the Rapid Development of Accurate, Low-Cost Home Diagnostics, Presented by Melissa R., Scout

P19: Single Circulating Tumor Cell Methylome Profiles from Patients with Metastatic Prostate Cancer: Insights for Precision Medicine, Presented by Mouadh B., Thomas Jefferson University

P20: Reaching Your Cancer Center Without an Automobile at Your Disposal: Real-World Data from the German WERA Alliance with Its Mainly Rural Catchment Area, Presented by Florian L., University Hospital Regensburg

P21: Spatial Single-Cell Mapping of Transcriptional Differences Across Genetic Backgrounds in Mouse Brains, Presented by Roy W., University of California, Los Angeles

P22: Smart Diagnostics: Leveraging Artificial Intelligence for Accurate At-Home COVID-19 Testing, Presented by Paxton T., University of Central Florida

P23: Enhanced Neural Cell Segmentation for Spatial Proteomics in Peripheral Somatosensory Ganglia, Presented by Milad IM., University of Delaware

P24: An Integrated Lab-on-a-Chip Device for Wastewater Surveillance of SARS-CoV-2, Presented by Mohammad DB., University of Kentucky

P25: FAST At-Home Diagnostic for Leishmania, Presented by Taralyn W., University of Miami

P26: An Omics Operating System Built for Scientists, by Scientists, Presented by Maryam H., Via Scientific

P27: Revolutionizing Biomedical Sensing with Miniaturized Polarizer, Presented by Hsin-Yi H., VisEra Technologies Company Ltd.

P28: CURE AI Predicts IL-15 as a Therapeutic Target in Renal Cancer: Biomarker Analysis of the Phase 3 JAVELIN Renal 101 Trial, Presented by Vitalay F., Numenos AI